Ivermectin and Nitazoxanide Combination Therapy for COVID-19
Clinical trial NCT04360356 · UNKNOWN
Trial details
- NCT number
- NCT04360356
- Sponsor
- Tanta University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2020-10-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.